The HINT1 protein, a member of the histidine triad (HIT) family, is highly conserved in diverse species and ubiquitously expressed in mammalian tissues. However, its precise function in mammalian cells is not known. As a result of its structural similarity to the tumor-suppressor protein FHIT, we used homozygous-deleted Hint1 mice to study its role in tumorigenesis. We discovered that after 2 to 3 years of age the spontaneous tumor incidence in Hint1 À/À mice was significantly greater than that in wildtype Hint1 þ / þ mice (Po0.05). Using a well-established mouse model of 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary carcinogenesis we found a marked and significant (Po0.05) increase in the incidence of mammary and ovarian tumors in both, Hint1 À/À and þ /À mice versus þ / þ mice. The Hint1 À/À and þ /À mice had similar tumor incidence and similar tumor histologies. Therefore, deletion of Hint1 in mice enhances both spontaneous tumor development and susceptibility to tumor induction by DMBA. In addition, since the Hint1 þ /À tumors retained expression of the unmutated wildtype allele, Hint1 is haplo-insufficient with respect to tumor suppression in this model system.
Introduction
A human cDNA that encodes the protein HINT1 (gi:47834342) was originally isolated in our laboratory using the yeast two-hybrid system during studies designed to isolate proteins that interact with the regulatory domain of protein kinase C b (Klein et al., 1998) . The encoded 13.7 kDa protein was initially named PKCI-1, for protein kinase C interacting protein-1. Since it contains a characteristic histidine triad (HIT) (His-X-His-X-His-X-X, where X is a hydrophobic amino acid) amino-acid sequence (Seraphin, 1992) , it is a member of the HIT protein family (Lima et al., 1996) . Therefore, this protein was subsequently renamed HINT1, for HIT nucleotide binding protein-1 (Su et al., 2003) .
The HIT proteins constitute an ancient conserved family of proteins with representative members present throughout evolution. The HIT protein superfamily consists of at least three subfamilies: HINT, FHIT, and GalT (Brenner, 2002) . The HINT subfamily, which includes human HINT1, is found in archaea, bacteria, and eucaryota, and contains a highly conserved C-terminal sequence (Lima et al., 1996) . The FHIT subfamily is found in eucaryota, but not in archaea or bacteria. The most prominent member FHIT (fragile locus HIT protein) is a known tumor-suppressor gene. It was originally isolated by linkage analysis at the human chromosome locus 3p14.2 (Ohta et al., 1996) , which encompasses the common fragile site FRA3B, the most common fragile site in the human genome. Hemi-and homozygous deletions within the Fhit locus have been observed in cell lines derived from several types of human cancer. In addition, deletions, hypermethylation, aberrant transcripts, and decreased expression of Fhit have been observed in multiple types of primary tumors (Huebner et al., 1998) . In breast cancer, alterations in the Fhit gene and protein have been associated with genomic instability, particularly in BRCA2-mutated breast tumors (Ingvarsson, 2001 ). These findings provide evidence that Fhit is a tumor-suppressor gene, but its precise mechanism of action of Fhit and the mechanism by which it affects tumor development are not known.
The GalT subfamily of HIT proteins consists of specific nucleoside monophosphate transferases, including galactose-1-phosphate uridylyltransferase (GalT). Except for the slightly altered HIT motif, members of the GalT subfamily share little overall sequence similarity with HINT or FHIT subfamily members. However, the three-dimensional structure of the monomer GalT is very similar to that of the HINT1 or FHIT homodimer, and GalT has the same fold in the HIT region of the protein and mode of nucleotide binding as the latter two proteins (Brenner et al., 1997) .
The three-dimensional structure of human HINT1 determined by X-ray crystallography revealed that this protein exists as a homodimer, and that the HIT forms a part of the binding loop for the a-phosphate of purine nucleotides (Lima et al., 1996 (Lima et al., , 1997 . Indeed, in vitro studies indicated that human HINT1 can bind various nucleotides, including AMP, ADP, and the diadenosine polyphosphates Ap 3 A and Ap 4 A (Lima et al., 1997; Lee et al., 2004) . Rabbit HINT1 also binds several purine nucleosides and nucleoside 5 0 -phosphates . In vitro the human and rabbit HINT1 proteins do not hydrolyse dinucleoside polyphosphates (Ap n A) or ATP (Lima et al., 1996; Brenner et al., 1997) , but they do hydrolyse ADP (Barnes et al., 1996; Lima et al., 1997) . Rabbit HINT1 and the yeast orthologue of HINT1, designated as HNT1, bind and hydrolyse the naturally occurring compound adenosine-5 0 -monophosphoramidate (AMP-NH 2 ) (Bieganowski et al., 2002) . Taken together, these findings suggest that HINT might mediate biological effects of unusual purine nucleotides.
Ap n A such as Ap 3 A and Ap 4 A have been known for many years, but their cellular functions are poorly understood. They are synthesized by aminoacyl-tRNA synthetases (Goerlich et al., 1982) and degraded by specific Ap 4 A and Ap 3 A hydrolases (Guranowski et al., 1989) . Their intracellular concentrations can be relatively high, ranging from 0.05 to 5 mM (Guranowski, 2004) . In Escherichia coli, cell division is associated with an increase in the concentration of Ap 4 A. In mammalian cells, Ap 3 A and Ap 4 A have been implicated in inhibition of ATP-sensitive potassium channels and regulation of intracellular levels of Ca 2 þ (Kisselev et al., 1998) , and when added to the medium at 10 mM, Ap 4 A induced apoptosis in cultures of human HL60, U937, Jurkat, and mouse VMRO cells (Vartanian et al., 1999) .
Since our discovery of HINT1 by its interaction with PKC in the yeast two-hybrid system (Klein et al., 1998) , other investigators have obtained evidence that HINT1 can also interact with other proteins, including the protein ATDC, which is thought to be involved in DNA repair (Brzoska et al., 1995) , the protein CDK7, which plays a role in the general apparatus of transcription (Korsisaari and Makela, 2000) , and MITF, a specific bHLH-zip transcription factor (Razin et al., 1999) . The latter studies are of particular interest since they indicated that Ap 4 A could modulate the transcriptional activity of MITF in mast cells (Razin et al., 1999) . However, none of these studies addressed the actual function of HINT1 in the intact animal. As a result of the structural similarity between the HINT1 and FHIT proteins we hypothesized that Hint1 can function as a tumor-suppressor gene. Therefore, in a previous study we used the technique of homologues recombination to develop mice in which the Hint1 gene is deleted (Su et al., 2003) . We found that Hint1 À/À mice develop normally but display increased susceptibility to induction of gastric tumors by the carcinogen NMBA. In addition, when mouse embryo fibroblasts were established from 13.5-day embryos and serially passaged the Hint1 À/À cells displayed an increase in growth rate and underwent spontaneous immortalization, whereas the Hint1 þ / þ cells senesced and ceased growing. Furthermore, the Hint1 À/À mouse embryo fibroblasts displayed increased resistance to cytotoxicity by ionizing radiation (Su et al., 2003) . To obtain further insights into the role of Hint1 in tumorigenesis, in the present study, we examined whether a deficiency in Hint1 expression in mice increases susceptibility to spontaneous tumor development and to the induction of mammary tumors by the carcinogen DMBA.
Results
Deletion of Hint1 in mice enhances susceptibility to the induction of mammary tumors by DMBA To investigate the potential role of Hint1 in the development of breast cancer, we induced mammary tumors in mice by treatment with the carcinogen DMBA during the time of ductal development (Medina et al., 1980) . Initially, we treated 40 Hint1 þ / þ , 40 Hint1 À/À, and 25 Hint1 þ /À mice with DMBA, as described in Materials and methods. Equal numbers of mice of each genotype were also treated with the corn oil vehicle. During the subsequent 20 weeks after the final dose of DMBA, 2 þ / þ and 3 À/À mice died of unknown causes. The time course of appearance of mammary tumors as determined by observation and palpation is shown in Figure 1 . None of the control corn-oil-treated mice developed observable or palpable tumors. The results are plotted as percent of mice with tumors versus time after treatment with DMBA. Mammary tumors were first detected in the DMBA-treated Hint1 þ /À mice at day 87, in the À/À mice at day 91, and in the þ / þ mice at day 94, after the final treatment. Thereafter, the incidence of mammary tumors in both the Hint1 þ /À and À/À mice continued to increase more rapidly Figure 1 Time course of the appearance of DMBA-induced mammary tumors in Hint1 þ / þ , þ /À, and À/À mice. Following DMBA treatment, mice were observed and palpated twice a week to detect mammary tumor formation, until they were killed 140 days after the final dose of DMBA. The differences in final tumor incidence between both the Hint1 þ /À and À/Àmutant mice and the wild-type mice are statistically significant (*: P ¼ 0.0374; **: P ¼ 0.0100, compared with Hint1 þ / þ mice).
Hint1 is a haplo-insufficient tumor suppressor in mice H Li et al than in the þ / þ mice. At 140 days after the final dose of DMBA, palpable mammary tumors were present in 2 of 38 (5.3%) of the DMBA-treated wild-type mice, which was consistent with the result reported by other investigators using a similar DMBA treatment protocol (Pierce et al., 1995; Witty et al., 1995; Aldaz et al., 1996) . At 140 days after the final dose of DMBA the incidence of observable mammary tumors in the living Hint1 þ /À and À/À mice after treatment with DMBA was seven out of 25 (28.0%) and 10 out of 37 (27.0%) mice, respectively. These values are significantly higher than that in the Hint1 þ / þ mice (Po0.05 and Po0.02, respectively). There is no statistically significant difference in mammary tumor incidence at 140 days between the þ /À and À/À groups of mice. The body weights of the DMBA-treated and control mice and of the three genotype groups of mice remained similar during their lifetime. However, at autopsy the DMBA-treated mice exhibited higher weights of the spleen and liver (data not shown).
Complete autopsies confirmed that none of the cornoil-treated mice developed tumors. At autopsy small lesions of the mammary gland and other organs that were not observed by palpation of the living mice were discovered in the DMBA-treated groups. All the grossly observed tumors were confirmed by histological analysis. The data on tumor incidence based on histopathology are summarized in Table 1 . There was a marked and statistically significant increase in the total incidence of tumors in the Hint1 þ /À and À/À mice versus the þ / þ mice, since the respective values were 52.0, 67.6 and 15.8% (Po0.02 and Po0.005, respectively, Table 1). In all three groups of mice the majority of these tumors were in the mammary gland. The incidence of mammary tumors in the Hint1 þ /À and À/À mice was similar and significantly greater than in the þ / þ mice (Po0.02 and Po0.01, respectively, Table 1 ). The mammary tissues were histologically classified into four types: adenocarcinoma, squamous cell carcinoma, adeno-squamous cell carcinoma, and nipple papilloma, based on previously described criteria (Cardiff et al., 2000) . Representative histological features of each type of mammary tumor are shown in Figure 2 . The incidence and multiplicity of each tumor type in each of the three genotypes are summarized in Table 2 .
Invasion of mammary carcinoma cells into surrounding striated muscle and adipose tissues was seen in tumors from mice of all three genotypes. In addition, in all three genotypes, we observed metastases of the mammary adenocarcinoma in the lungs of some of these mice, which had the same histologies as the primary tumors.
The administration of DMBA to virgin female mice can also induce ovarian tumors (Buters et al., 2003) . Indeed, in the present study 2.6% of the DMBA-treated Hint1 þ / þ mice developed malignant granulosa cell tumors of the ovary. This is consistent with previous findings (Buters et al., 2003) . It is of interest that, as in the case of mammary tumors, the Hint1 mutant mice were also much more susceptible to the induction of ovarian tumors than the wild-type mice. Thus, the incidence of ovarian tumors in the Hint1 þ /À and À/À mice was 20.0 and 21.6%, respectively, and all these were the malignant granulosa cell tumor type. When compared to the incidence of ovarian tumors in the þ / þ mice (2.6%) these differences are statistically significant (Po0.05 and Po0.02, respectively, Table 1 ). In addition, the ovarian tumors that developed in the Hint1 þ /À and À/À mice were more malignant than those in the þ / þ mice, since they displayed a greater increase in mitotic cells ('pathological mitosis', Figure 2 ), and metastasized to distant sites in the peritoneal cavity, including adipose tissues and the pancreas (data not shown).
It is known that DMBA can induce tumors at additional tissue sites in mice (Archuleta et al., 1992; Aldaz et al., 1996; Buters et al., 2003) . In the present study, there was a 2.6% incidence of papillomas of the skin in the DMBA-treated Hint1 þ / þ mice and a statistically significantly higher incidence (18.9%) of these tumors in Hint1 À/À mice (Table 1) . These tumors were confined to the head and neck, including the lip, nose, ear, and eyelid, and may have been induced by local exposure to the carcinogen during the gastric intubation. There was also a 2.7% incidence of adenocarcinoma of the forestomach in the DMBAtreated Hint1 À/À mice (Table 1), but this incidence was not significantly different from that of the þ / þ mice. Although DMBA has been reported to induce lympho- Hint1 is a haplo-insufficient tumor suppressor in mice H Li et al mas in mice (Qing et al., 1997) , we did not find lymphomas in any of our DMBA-treated mice. We did observe enlargement of the spleen in our DMBAtreated mice, but there was no statistically significant difference between the Hint1 þ / þ , þ /À, and À/À mice, with respect to the percent of mice with enlarged spleens and the average spleen weight. The lack of lymphomas may reflect the genetic background of our mice or the fact that all the mice were killed 20 weeks after the final dose of DMBA. Hint1 is a haplo-insufficient tumor suppressor in mice H Li et al It is of interest that an increase in skin papillomas was seen in the Hint1 À/À but not in the Hint1 þ /À mice (Table 1) . On the other hand, the fact that the increased susceptibility to the induction of both mammary and ovarian tumors in the Hint1 þ /À mice was fairly similar to that of the À/À mice (Table 1) suggests that the Hint1 gene is haplo-insufficient with respect to tumor suppression at these organ sites. Previous carcinogenesis studies with mice deficient in expression of the Fhit gene suggest that this gene is also haplo-insufficient as a tumor suppressor (Fong et al., 2000) . Comparing tumor multiplicity among the three genotype groups, we found that Hint1 þ /À and À/À mice had an average of 2.5 tumors of various types per tumor-bearing mice, whereas in the Hint1 þ / þ mice, the corresponding number was 2.0. This difference was statistically significant. However, we did not find a significant difference among these three groups when the multiplicity of tumors at each organ site was compared, even though Hint1 þ /À and À/À mice had a higher incidence of each tumor type than the þ / þ mice (Table 1) .
Comparative levels of expression of HINT1 and FHIT As a result of the homology between HINT1 and FHIT (see Introduction) it was of interest to analyse the levels of expression of both proteins in various normal tissues of our three genotypes of mice, and in the mammary and ovarian tumors that developed in these mice after treatment with DMBA. Western blot analysis using an antibody specific to HINT1 indicated that in the Hint1 þ / þ mice this protein was expressed at high levels in a wide variety of normal tissues, including the cerebrum, cerebellum, colon, kidney, thymus, thyroid, stomach, liver, pancreas, adrenal gland, testis, and ovary ( Figures  3a and 4b) . In the heart, lung, spleen, muscle, and skin the expression levels were relatively low. Since the normal mammary gland of virgin mice is mainly adipose tissue, we did not examine this tissue. As expected, in the set of normal tissues obtained from the Hint1 þ /À mice there was a reduced level of this protein, and in the set of normal tissues obtained from the Hint1 À/À mice the HINT1 protein was not expressed (Figure 3a) . The FHIT protein was also expressed in most of the normal tissues from the Hint1 þ / þ mice (Figure 3a) . It is of interest that in the kidney, liver, testis, and ovary the levels of the FHIT protein were significantly higher in the Hint1 þ /À and Hint1 À/À mice than the levels in the corresponding tissues from the Hint1 þ / þ mice (Po 0.05, Figure 3b ). These findings suggest that in some tissues loss of expression of Hint1 in our Hint1 deficient mice may be partially compensated by increased expression of Fhit.
Frozen samples of mammary and ovarian tumors were selected for analysis if they were of sufficient size and histological homogeneity (>95% homogeneity). Extracts were examined by Western blot analysis for the expression of HINT1 and FHIT. We found that the two mammary adenocarcinomas from the Hint1 þ / þ mice expressed relatively high levels of the HINT1 protein; Figure 3 (a) Western blot analysis of HINT1 and FHIT protein levels in normal tissues from adult Hint1 þ / þ , þ /À, and À/À mice. The data shown are representative of tissues obtained from four adult male and female (virgin) mice from each genotype group at 3-5 months of age. Actin was used as an internal loading control. HINT1 protein levels are also quantified by densitometry and normalized to the corresponding actin level, and the expression ratio is presented in the lower bars. (b) FHIT expression in four normal tissues was quantified by densitometry and normalized to the corresponding actin level. Samples from four mice for each tissue in each genotype group were used in this statistical analysis. Hint1 is a haplo-insufficient tumor suppressor in mice H Li et al the four mammary tumors (adenocarcinoma and squamous cell carcinoma) from the Hint1 þ /À mice retained expression of Hint1, and, as expected, in three mammary adenocarcinomas from the Hint1 À/À mice the HINT1 protein was not expressed (Figure 4a) . Similarly, Hint1 was expressed in two ovarian tumors from þ /À mice. Thus, it appears that in the wild-type mice mammary and ovarian tumors can develop without suppression of Hint1 expression. Expression of Hint1 in the mammary and ovarian tumors from the þ /À mice suggests that this gene is haplo-insufficient with respect to tumor suppression. Variable levels of the FHIT protein were seen in the mammary and ovarian tumors (Figure 4a and b) , but due to the small number of Hint1 þ / þ tumors it was not possible to analyse the possible differences between the three genotypes.
We isolated genomic DNA from same of the histologically homogeneous tumors and confirmed the genotypes of tumors obtained from the Hint1 þ / þ , þ /À and À/À mice using PCR analysis. These included one mammary tumor that developed in the Hint1 þ / þ , nine mammary tumors that developed in the Hint1 þ /À, and one mammary tumor that developed in the Hint1 À/À mice. Representative results are shown in Figure 5a . Total RNA was also isolated for detection of Hint1 mRNA by RT-PCR (Figure 5b ). We also sequenced the Hint1 mRNA RT-PCR product from these tumors and found no mutations or deletions (data not shown). Therefore, the HINT1 protein that is expressed at significant levels in the Hint1 þ / þ and þ /À tumors, that was detected by Western blot analysis (Figure 4) , is presumably the wild-type protein.
Deletion of Hint1 in mice enhances spontaneous tumor development in aging mice
In a previous study (Su et al., 2003) and in the current study we did not observe the development of spontaneous tumors in the Hint1 deficient mice during the first 3-6 months of age. To examine possible effects of aging on spontaneous tumor development in these mice we initiated a 3-year study with 60 Hint1 þ / þ and 60 À/À mice and killed about 10 mice from each group at 6 month intervals. During the course of this study, 5 þ / þ mice (8.3%) and 8 À/À mice (13.3%) died of unknown causes. All of the other mice appeared grossly normal. Groups of mice were killed at the designated ages (Table 3) and complete autopsies performed. Normal tissues, as well as samples from apparently diseased tissues, were fixed in buffered formalin, and examined histologically after hematoxylin/eosin Groups of untreated mice were killed at the indicated age, and complete autopsies and histological analysis were performed. 'Tumor incidence' is the percent of mice bearing any type of tumor in the indicated group. a P ¼ 0.0413; b P ¼ 0.0297; c P ¼ 0.0170; compared with Hint1 +/+ mice.
Hint1 is a haplo-insufficient tumor suppressor in mice H Li et al staining, for the presence of hyperplasia, dysplasia, papilloma, adenoma, and carcinoma. Only one of the Hint1 þ / þ mice developed a tumor and this was not observed until 3 years of age. This was a granulosa cell carcinoma of the ovary. However, a spontaneous tumor of the ovarian granulosa cell tumor type was discovered in a À/À mouse within 1 year of age, and within 2-3 years about 50-80% of the Hint1 À/À mice displayed various types of spontaneous tumors (Po0.05, Table 3 ). These spontaneous tumors included nine malignant granulosa cell tumors of the ovary, two mammary adenocarcinomas, two undifferentiated sarcomas, two hepatocellular carcinomas, and one lung adenocarcinoma. The histologies of the mammary adenocarcinoma and granulosa cell ovarian tumors were remarkably similar to those of the earlier occurring mammary and ovarian tumors induced by DMBA in the Hint1 þ / þ and À/À mice (data not shown). Representative histologies of undifferentiated sarcoma, hepatocellular carcinoma, and lung adenocarcinoma are shown in Figure 2 . It is of interest that the untreated Hint1 þ / þ mice had a low overall tumor incidence even at 3 years of age. These mice have a C57BL/6 and 129/SvJ mixed genetic background. It is known that the C57BL/6 mice have a low susceptibility to tumor formation (Malkinson and Thaete, 1986) . Although 10% of 129/Sv mice develop tumors in the testes, the 129/SvJ is derived from the 129/Sv strain and an unknown strain (Threadgill et al., 1997) , and the incidence of spontaneous tumors in 129/SvJ mice is not known. This mixed genetic background may explain the low spontaneous tumor incidence in our Hint1 þ / þ mice.
Discussion
The present study indicates that mice deficient in the Hint1 gene are more susceptible to the induction of both mammary and ovarian tumors by the carcinogen DMBA. Mammary tumors develop more rapidly in the Hint1 þ /À and À/À mice than in the þ / þ mice (Figure 1 ). The incidence of these tumors and overall tumor multiplicity in both Hint1 þ /À and À/À mice is significantly greater than in the Hint1 þ / þ mice ( Table 1 ). The DMBA induced mammary tumors included adenocarcinoma, squamous cell carcinoma, adeno-squamous cell carcinoma, and nipple papilloma ( Table 2) . Deletion of Hint1 also significantly increased the incidence of ovarian tumors in DMBA-treated mice, and was also associated with an increase in the incidence of papillomas of the skin of the head and neck (Table 1) . The findings in the present carcinogenesis study employing DMBA, coupled with our previous study indicating that Hint1 À/À mice display a marked increase in susceptibility to the induction of gastric tumors by the carcinogen NMBA (Su et al., 2003) , provide evidence that Hint1 is a novel tumor-suppressor gene that can influence tumor susceptibility in multiple tissues. Furthermore, in the present study we found that with aging untreated Hint1 À/À mice developed a much higher incidence of tumors than Hint1 þ / þ mice with incidences at 3 years of age of 83.3 versus 14.3%, respectively (Po0.05, Table 3 ). This indicates that the tumor-suppressive effects of Hint1 are not confined to susceptibility to chemical carcinogenesis. Other investigators did not find an increase in spontaneous tumor in Hint1 À/À mice (Korsisaari et al., 2003) . This may be because they followed the mice for only 18 months, the number of mice included in their study was not sufficient, and/or their mice have a different genetic background. Our evidence that Hint1 is a novel tumor suppressor for multiple tissues is supported by a recent study in human non-small-cell lung cancer (NSCLC) cell lines (Yuan et al., 2004) . Treatment of these cells with the drug 5-aza-2 0 -deoxycytidine to upregulate the expression of repressed genes led to a marked increase in expression of Hint1 and growth inhibition. Furthermore, transfection of the Hint1 cDNA into untreated NSCLC cells caused growth inhibition in two of these cell lines and inhibited the tumorigenecity of one of these cell lines (Yuan et al., 2004) . We found that transfection of a Hint1 cDNA into MCF-7 human breast cancer cells also inhibits their growth (unpublished studies). Therefore, Hint1 may also have tumorsuppressive activity in multiple human tissues.
It is of interest that not only Hint1 À/À but also Hint1 þ /À mice were more susceptible to the induction of mammary and ovarian tumors than wild-type Hint1 þ / þ mice (Table 1 and Figure 1 ). In addition, some of these tumors continue to express the HINT1 protein encoded by the wild-type Hint1 allele (Figure 4 ). These findings suggest that the Hint1 gene is haplo-insufficient with respect to tumor suppression. This also appears to be the case with the Fhit gene (Zanesi et al., 2001) . Over 30 years ago, Knudson (Knudson, 1971 ) advanced a model of tumorigenesis specifying that inactivation of both alleles of a tumor-suppressor gene was required to promote tumor progression. Indeed, classical tumorsuppressor genes are thought to require mutation or loss of both alleles to facilitate tumor progression. However, there are now several examples of functional effects of heterozygous loss-of-function mutations in genes and these can be of considerable importance in tumor development (Quon and Berns, 2001) . For example, inactivation of a single allele of the gene encoding the cyclin-dependent kinase inhibitor p27
Kip1 is sufficient to sensitize mice to radiation and carcinogen-induced tumorigenesis. The tumors preserve expression of the unmutated wild-type allele, demonstrating that loss of a single tumor-suppressor gene allele can provide a selective advantage during tumorigenesis (Fero et al., 1998) . Other examples of haplo-insufficiency of tumorsuppressor genes include the genes Fhit (Fong et al., 2000) , p53 (Venkatachalam et al., 1998) , Dmp1 gene (Inoue et al., 2001) , and the p21 cip1 gene (Jackson et al., 2003) .
We have searched the tumor-suppressor gene database and found that none of the previously described tumor-suppressor genes have orthologues in procaryotes. However, Hint1 is a highly conserved gene, since its orthologues are present in a broad range of life forms. The HINT subfamily of HIT proteins has greater than 94% overall amino-acid sequence identity between known mammalian orthologues, and the human HINT1 shares 53% overall sequence identity with its orthologue in maize. Even the Mycoplasma genitalium genome, which is the smallest known genome of any free-living organism (only 580 kb), contains a HIT homologue, that shares over 30% identity with human HINT1 full sequence (Lima et al., 1996) . Strong sequence conservation suggests that these proteins play a fundamental role in cell biology. Furthermore, the HINT1 protein is expressed in many tissues of adult mice (Figure 3) , and in a variety of rodent and human cell lines (Klein et al., 1998) . It is present in both the nucleus and cytoplasm, and in the cytoplasm it is localized to cytoskeletal structures (Brzoska et al., 1996) . Possible functions of Hint1 are discussed in the Introduction. However, future studies are required to determine the mechanism by which Hint1 functions as a tumor-suppressor gene and the relevance of Hint1 deficiency to the development of specific types of human cancer.
Materials and methods
Confirmation and genotyping of Hint1 þ / þ , þ /À, and À/À mice Mice were generated in the Columbia University Health Sciences animal facility as previously described (Su et al., 2003) . The genotypes of Hint1 þ / þ , þ /À, and À/À mice were confirmed with the polymerase chain reaction using the forward primer 5 0 -GCC CCC TGT AAA GTG CAG AC-3 0 and the reverse primer 5 0 -CGC CCC AGT TAG TTA GT CAG-3 0 to generate a 339 bp product from the wild-type allele, and the forward primer 5 0 -GCC TGA AGA ACG AGA TCA GC-3 0 and the reverse primer 5 0 -CGC CCC AGT TAG TTA GT CAG-3 0 to generate a 285 bp product from the mutant allele using genomic DNA extracted from the tails of Hint1 þ / þ , þ /À, and À/À mice.
Carcinogenicity study
The strategy for the carcinogenicity study followed a wellestablished mouse model of DMBA-induced tumors of the mammary gland (Yao et al., 1999) 
, and À/À (n ¼ 40) virgin female mice were given five intragastric doses of DMBA (Sigma) over the course of 5 weeks, starting at 8 weeks of age, at 1 mg per dose per mouse. DMBA was dissolved in corn oil at a concentration of 5 mg/ml. This mixture was heated at 371C and shaken vigorously to fully dissolve the DMBA. The material was administered by oral gavage by inserting a curved blunt-tipped needle attached to a 1 ml syringe into the midthroat of mice and injecting 200 ml of the DMBA solution. As a control, equal numbers of mice of the same age and in each genotype group were administered the same dose of only the corn oil vehicle. Both experimental and control mice were housed in the absence of males, to avoid pregnancy and lactation. All the mice were examined twice a week by inspection and palpation for mammary or other tumors, until they were killed 20 weeks after the final DMBA dose. Complete necropsies were carried out at the first sign of morbidity, or when visible tumors were >1 cm in size. All remaining animals were necropsied at the termination of the experiment. Samples of all the tissues except for blood and bone marrow, and any apparent tumors were excised. Samples of these tumors and apparently normal tissues were fixed in buffered formalin for subsequent analysis. Liver and spleen weights were measured to evaluate toxicity effects.
Spontaneous tumor development in untreated mice
A total of 120 mice, including 60 Hint1 þ / þ and 60 Hint1 À/À mice, were placed on a time study, untreated, and observed weekly by inspection and palpation for up to 3 years. They were randomly divided into six age groups, ranging from 6 months to 3 years, with 10 mice per group per genotype. Mice were killed at the designated age, or when they appeared unhealthy, either because of visible lesions, morbidity, dull coat, hunched appearance, or significant weight loss. Mice killed because of these physical conditions were included in the scoring for the next age group. Complete autopsies were performed on all these killed mice. Samples of all the tissues except for blood and bone, as well as apparently diseased tissues, were removed and fixed in buffered formalin.
Histological analysis
Fixed tissues from mice were examined histologically by three pathologists after hematoxylin/eosin staining. The numbers of animals bearing histologically confirmed tumors in the mammary gland, ovary, and other tissues were scored (see Table 1 ).
Immunoblot analysis
Tumors or normal tissues from mice were homogenized in cell lysis buffer (50 mM Hepes, 150 mM NaCl/2.5 mM, EGTA/1 mM EDTA/1 mM, DTT/0.1% Tween 20/10% glycerol, final pH 7.5) together with protease inhibitors (10 mg/ml leupeptin, 10 mg/ml aprotinin, 1 mM PMSF). The lysates were incubated on ice for 15 min and then sonicated for three 10 s bursts, followed by centrifugation at 10 000 g at 41C for 5 min, and the supernatant fraction was collected. Protein content was standardized between samples by Bradford assay (BioRad). Western blot analysis was performed with previously described anti-human HINT1 antibody and anti-human FHIT antibodies (Klein et al., 1998) , and an antibody to b-actin (clone AC-40, Sigma) was used as a loading control.
Hint1 mRNA sequencing DNA from tumors was isolated and tumor genotypes were again confirmed by PCR as described above. Total RNA from mammary tumors of Hint1 þ / þ , þ /À, and À/À mice was purified and Hint1 mRNA was reverse transcribed using the SuperScript (BioRad) kit and amplified by PCR using Pfu Turbo DNA Polymerase (Stratagene). In total, 35 cycles were performed using primers 5 0 -GCG ATG GCT GAC GAG ATT-3 0 and 5 0 -GCA AAA CTA CGT GTG CCA TT-3 0 . The PCR products were sequenced in DNA Analysis and Sequencing Facility at Herbert Irving Comprehensive Cancer Center, Columbia University. Sequences were compared with the published cDNA sequence for mouse Hint1 and with sequence data we obtained from normal tissues of wild-type mice.
Statistical analysis
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